Mauna Kea Technologies and V7 announced their partnership to develop a cutting-edge infrastructure for AI applications with Cellvizio. Mauna Kea and V7 will collaborate to establish a strategic data repository of clinically-augmented, curated and annotated Cellvizio images. This foundational data asset will spearhead Mauna Kea?s forthcoming AI-driven innovations, including: - Future AI-based decision support applications for physicians, in oncology and immunology, benefiting from both in-house and collaborative developments with premier academic and industry partners; - Foundational advanced digital biomarker models to expedite drug development, refine disease monitoring and improve the assessment of pathology states in the areas of cancer and food intolerance; and - Continuous innovation catalyst, based on the actionable in-procedure data generated by Cellvizio, to improve product usability and physician learning experience, or develop proactive maintenance strategies.

The entire Mauna Kea Technologies ecosystem, from its partners to its customers, will benefit from this unique combined experience with V7 through the delivery of high-end, future-proof features.